Intellia Therapeutics, Inc.

NTLANASDAQ Global Market·USD·Closed

NTLANASDAQ·USD·Closed

$10.68

−3.70%

$10.68

−$0.41 (3.70%)

52W Range

13thpctl

Volume

0.45×avg

Mkt Cap

1.20BUSD

P/E

-3.0TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

13thpctl

Volume

0.45×avg

Market Cap

1.20BUSD

P/E Ratio

-3.0TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+59.6% / yr

Operating margin-636.6%

ROIC-60.0%

Financially safe

Stretched

Debt / equity0.13×

Interest coverage0.0×

Current ratio6.10×